SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-153227
Filing Date
2015-04-28
Accepted
2015-04-28 17:14:53
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d902386d10q.htm 10-Q 480092
2 EX-31.1 d902386dex311.htm EX-31.1 6187
3 EX-31.2 d902386dex312.htm EX-31.2 6230
4 EX-32.1 d902386dex321.htm EX-32.1 3651
11 GRAPHIC g902386tx_pg17.jpg GRAPHIC 110504
  Complete submission text file 0001193125-15-153227.txt   3346983

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20150331.xml EX-101.INS 309953
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20150331.xsd EX-101.SCH 35817
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20150331_cal.xml EX-101.CAL 46578
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20150331_def.xml EX-101.DEF 87064
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20150331_lab.xml EX-101.LAB 285135
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20150331_pre.xml EX-101.PRE 191874
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 15799563
SIC: 2834 Pharmaceutical Preparations